Vir Biotechnology
217 hedge funds and large institutions have $698M invested in Vir Biotechnology in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 63 increasing their positions, 80 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6.21% more ownership
Funds ownership: 77.03% → 83.24% (+6.2%)
2% more funds holding
Funds holding: 212 → 217 (+5)
21% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 80
Holders
217
Holding in Top 10
5
Calls
$1.71M
Puts
$340K
Top Buyers
| 1 | +$8.15M | |
| 2 | +$6.14M | |
| 3 | +$5.88M | |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
+$3.72M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.2M |
Top Sellers
| 1 | -$21.2M | |
| 2 | -$4.24M | |
| 3 | -$3.29M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.85M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.64M |
